Primary Site >> Colorectal Cancer
Gene >> LATS2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Identifying a region of interest in site- and stage-specific colon cancer on chromosome 13. PMID: 14597449 |
Ref: Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. PMID: 17711579 |
Ref: MicroRNA-372 is associated with poor prognosis in colorectal cancer. PMID: 22456107 Ref: Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors. PMID: 22660396 |
Ref: LATS2 suppresses oncogenic Wnt signaling by disrupting beta-catenin/BCL9 interaction. PMID: 24360964 |
Ref: Expression of hippo pathway in colorectal cancer. PMID: 24976283 |
Ref: MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. PMID: 26101704 |
Ref: Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer. PMID: 26370619 Ref: MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2. PMID: 27602163 |
Ref: LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion. PMID: 29502343 Ref: Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells. PMID: 29956753 Ref: RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. PMID: 30037330 |